<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.otf"); }
.f1 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.otf"); }
.f2 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.otf"); }
.f3 { font-family:ff2,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff10; src: url("10.otf"); }
.f4 { font-family:ff10,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="793" src="page4.png"">
<div class="txt" style="position:absolute; left:37px; top:48px;"><span class="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">H. Nadeeshani, J. Li, T. Ying et al.</span></div>
<div class="txt" style="position:absolute; left:49px; top:67px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Currently, several studies have shown that NMN, the NAMPT</span></div>
<div class="txt" style="position:absolute; left:37px; top:78px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">reaction product, is able to be utilised to trigger the SIRT1 activity</span></div>
<div class="txt" style="position:absolute; left:37px; top:87px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,127,173,1);">[27]. It has been shown that when there is not adequate NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+</span></div>
<div class="txt" style="position:absolute; left:37px; top:99px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels, SIRT1 becomes unable to block hypoxia-inducible factor 1</span></div>
<div class="txt" style="position:absolute; left:37px; top:109px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">alpha (HIF-1) and elevated levels of which blocks the communica-</span></div>
<div class="txt" style="position:absolute; left:37px; top:120px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tion between mitochondria and nucleus at the cellular level and</span></div>
<div class="txt" style="position:absolute; left:37px; top:130px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">between adipose tissue and hypothalamus at the systemic level</span></div>
<div class="txt" style="position:absolute; left:37px; top:141px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,127,173,1);">[28]. The resulting interruption in mitochondria and nuclear com-</span></div>
<div class="txt" style="position:absolute; left:37px; top:151px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">munication causes swift reduction in mitochondrial function that</span></div>
<div class="txt" style="position:absolute; left:37px; top:162px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">leads to the development of age-associated complications and dis-</span></div>
<div class="txt" style="position:absolute; left:37px; top:172px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">eases. Nevertheless, the particular communication and mitochon-</span></div>
<div class="txt" style="position:absolute; left:37px; top:182px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">drial function can be restored by the administration of NMN as</span></div>
<div class="txt" style="position:absolute; left:37px; top:191px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">precursor [24]. Causes for reducing NAD+ levels when</span></div>
<div class="txt" style="position:absolute; left:37px; top:203px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">aging and mechanism underlying anti-aging activity of NMN are</span></div>
<div class="txt" style="position:absolute; left:37px; top:214px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">illustrated in Fig. 4. The nutraceutical industry has already started</span></div>
<div class="txt" style="position:absolute; left:37px; top:224px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">to market NMN aggressively as a highly efﬁcient and viable anti-</span></div>
<div class="txt" style="position:absolute; left:37px; top:233px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">aging health product to enhance the NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels [15], thus to pro-</span></div>
<div class="txt" style="position:absolute; left:37px; top:245px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">vide longevity to the general population. In addition, many studies</span></div>
<div class="txt" style="position:absolute; left:37px; top:256px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">are carried out to investigate the potential anti-aging activity of</span></div>
<div class="txt" style="position:absolute; left:37px; top:266px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN and their applicability and usability.</span></div>
<div class="txt" style="position:absolute; left:37px; top:289px;"><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Promises and efﬁcacy as an anti-aging health product</span></div>
<div class="txt" style="position:absolute; left:49px; top:310px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Many studies have been carried out to investigate the promises</span></div>
<div class="txt" style="position:absolute; left:37px; top:321px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and efﬁcacy of NMN as an anti-aging health product for managing</span></div>
<div class="txt" style="position:absolute; left:37px; top:331px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and regulating aging and age-associated complications and</span></div>
<div class="txt" style="position:absolute; left:37px; top:342px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">diseases using cell culture, animal models and human clinical</span></div>
<div class="txt" style="position:absolute; left:413px; top:48px;"><span class="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Journal of Advanced Research 37 (2022) 267–278</span></div>
<div class="txt" style="position:absolute; left:306px; top:67px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">investigations. </span><span class="f3" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">In vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">studies, which have been carried out to</span></div>
<div class="txt" style="position:absolute; left:306px; top:78px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">investigate anti-aging therapeutic effects of NMN administration,</span></div>
<div class="txt" style="position:absolute; left:306px; top:88px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">are summarised in Table 1, including animal models, given NMN</span></div>
<div class="txt" style="position:absolute; left:306px; top:99px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">dose, duration and observed effects. According to Yoshino et al.</span></div>
<div class="txt" style="position:absolute; left:306px; top:108px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,127,173,1);">[23], during the aging process, NAMPT and NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels signiﬁ-</span></div>
<div class="txt" style="position:absolute; left:306px; top:120px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cantly decrease in various organs and NMN administration could</span></div>
<div class="txt" style="position:absolute; left:306px; top:129px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">enhance NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels (from 500 to 1550 pmol/mg-tissue), insulin</span></div>
<div class="txt" style="position:absolute; left:306px; top:141px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">secretion, insulin sensitivity and lipid proﬁle in age-induced type</span></div>
<div class="txt" style="position:absolute; left:306px; top:151px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2 diabetic mice. Administration of NMN also can restore gene</span></div>
<div class="txt" style="position:absolute; left:306px; top:162px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">expression linked to circadian rhythm, inﬂammatory response</span></div>
<div class="txt" style="position:absolute; left:306px; top:172px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and oxidative stress, and improve hepatic insulin sensitivity, par-</span></div>
<div class="txt" style="position:absolute; left:306px; top:182px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tially by SIRT1 activation.</span></div>
<div class="txt" style="position:absolute; left:318px; top:193px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">De Picciotto et al. [29] found that NMN supplementation was</span></div>
<div class="txt" style="position:absolute; left:306px; top:202px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">capable of restoring NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels (by threefold), vascular SIRT1</span></div>
<div class="txt" style="position:absolute; left:306px; top:214px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">activity, maximum carotid artery endothelium-dependent dilation,</span></div>
<div class="txt" style="position:absolute; left:306px; top:224px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and nitric oxide-mediated carotid artery endothelium-dependent</span></div>
<div class="txt" style="position:absolute; left:306px; top:235px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">dilation in mice. Kawamura et al. [30] have reported that NMN</span></div>
<div class="txt" style="position:absolute; left:306px; top:245px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">retained in animals for longer period than nicotinamide. NMN</span></div>
<div class="txt" style="position:absolute; left:306px; top:254px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">resulted in a higher yield of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(80 nmol/g of liver tissue) in sal-</span></div>
<div class="txt" style="position:absolute; left:306px; top:266px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">vage biosynthesis pathway activating higher response of SIRT1</span></div>
<div class="txt" style="position:absolute; left:306px; top:277px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">than nicotinamide.</span></div>
<div class="txt" style="position:absolute; left:318px; top:287px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Mills et al. [10] found that devoid of any apparent deleterious</span></div>
<div class="txt" style="position:absolute; left:306px; top:298px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">effect or toxicity, NMN effectively suppressed aging-induced body</span></div>
<div class="txt" style="position:absolute; left:306px; top:308px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">weight gain and ameliorated eye dysfunction in mice. It main-</span></div>
<div class="txt" style="position:absolute; left:306px; top:318px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tained healthy plasma lipid proﬁle, insulin sensitivity, physical</span></div>
<div class="txt" style="position:absolute; left:306px; top:329px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">activity, energy metabolism and other physiopathologies. Addi-</span></div>
<div class="txt" style="position:absolute; left:306px; top:339px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tionally, NMN supplementation averted alterations in age-</span></div>
<div class="txt" style="position:absolute; left:295px; top:380px;"><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Aging</span></div>
<div class="txt" style="position:absolute; left:215px; top:432px;"><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Downregulation of energy production in mitochondria</span></div>
<div class="txt" style="position:absolute; left:238px; top:466px;"><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Depletion and reduction of NAD</span><span class="f4" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">levels</span></div>
<div class="txt" style="position:absolute; left:201px; top:521px;"><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Increasing NAD</span><span class="f4" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">consuming enzymes</span></div>
<div class="txt" style="position:absolute; left:135px; top:551px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Sirtuins</span></div>
<div class="txt" style="position:absolute; left:135px; top:560px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Deacetylation,</span></div>
<div class="txt" style="position:absolute; left:135px; top:569px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">deglutarylase,</span></div>
<div class="txt" style="position:absolute; left:135px; top:577px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">lipoamidase,</span></div>
<div class="txt" style="position:absolute; left:135px; top:586px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">demalonylase</span></div>
<div class="txt" style="position:absolute; left:135px; top:595px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and</span></div>
<div class="txt" style="position:absolute; left:135px; top:604px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">desuccinylase</span></div>
<div class="txt" style="position:absolute; left:135px; top:613px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">activities</span></div>
<div class="txt" style="position:absolute; left:189px; top:551px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">CD38/CD157</span></div>
<div class="txt" style="position:absolute; left:189px; top:560px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Production of</span></div>
<div class="txt" style="position:absolute; left:189px; top:569px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cyclic ADP-</span></div>
<div class="txt" style="position:absolute; left:189px; top:577px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ribose and</span></div>
<div class="txt" style="position:absolute; left:189px; top:586px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">nicotinamide</span></div>
<div class="txt" style="position:absolute; left:242px; top:551px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">PARP</span></div>
<div class="txt" style="position:absolute; left:242px; top:560px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Formation of</span></div>
<div class="txt" style="position:absolute; left:242px; top:569px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">branched</span></div>
<div class="txt" style="position:absolute; left:242px; top:577px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ADP-ribose</span></div>
<div class="txt" style="position:absolute; left:242px; top:586px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">polymers for</span></div>
<div class="txt" style="position:absolute; left:242px; top:595px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">DNA</span></div>
<div class="txt" style="position:absolute; left:242px; top:604px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">repairing</span></div>
<div class="txt" style="position:absolute; left:293px; top:551px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">TNKS</span></div>
<div class="txt" style="position:absolute; left:293px; top:559px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">poly-ADP-</span></div>
<div class="txt" style="position:absolute; left:293px; top:568px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ribosylation</span></div>
<div class="txt" style="position:absolute; left:293px; top:577px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">activity and</span></div>
<div class="txt" style="position:absolute; left:293px; top:586px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">post-</span></div>
<div class="txt" style="position:absolute; left:293px; top:595px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">translational</span></div>
<div class="txt" style="position:absolute; left:293px; top:604px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">modification</span></div>
<div class="txt" style="position:absolute; left:293px; top:613px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of acceptor</span></div>
<div class="txt" style="position:absolute; left:293px; top:622px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">proteins</span></div>
<div class="txt" style="position:absolute; left:341px; top:551px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">BST1</span></div>
<div class="txt" style="position:absolute; left:341px; top:559px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Synthesis of</span></div>
<div class="txt" style="position:absolute; left:341px; top:568px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cyclic ADP-</span></div>
<div class="txt" style="position:absolute; left:341px; top:577px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ribose and</span></div>
<div class="txt" style="position:absolute; left:341px; top:586px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">nicotinate-</span></div>
<div class="txt" style="position:absolute; left:341px; top:595px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">adenine</span></div>
<div class="txt" style="position:absolute; left:341px; top:604px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">dinucleotide</span></div>
<div class="txt" style="position:absolute; left:341px; top:613px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">phosphate</span></div>
<div class="txt" style="position:absolute; left:415px; top:550px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Reduction of</span></div>
<div class="txt" style="position:absolute; left:415px; top:561px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NAD+</span></div>
<div class="txt" style="position:absolute; left:415px; top:571px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">biosynthesis</span></div>
<div class="txt" style="position:absolute; left:415px; top:581px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">by chronic</span></div>
<div class="txt" style="position:absolute; left:415px; top:591px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">inflammation</span></div>
<div class="txt" style="position:absolute; left:415px; top:602px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and oxidative</span></div>
<div class="txt" style="position:absolute; left:415px; top:612px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">stress</span></div>
<div class="txt" style="position:absolute; left:156px; top:673px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN</span></div>
<div class="txt" style="position:absolute; left:140px; top:684px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">supplementation</span></div>
<div class="txt" style="position:absolute; left:225px; top:669px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Increase NAD+</span></div>
<div class="txt" style="position:absolute; left:230px; top:678px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">biosynthesis</span></div>
<div class="txt" style="position:absolute; left:218px; top:687px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(Salvage and Preiss-</span></div>
<div class="txt" style="position:absolute; left:220px; top:696px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Handler pathways)</span></div>
<div class="txt" style="position:absolute; left:307px; top:672px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Increase NAD</span><span class="f4" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">+</span></div>
<div class="txt" style="position:absolute; left:309px; top:684px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels in body</span></div>
<div class="txt" style="position:absolute; left:393px; top:673px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Reverse the</span></div>
<div class="txt" style="position:absolute; left:390px; top:684px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">aging process</span></div>
<div class="txt" style="position:absolute; left:37px; top:723px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Fig. 4. </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Causes for reducing NAD+ levels when aging and mechanism underlying anti-aging activity of NMN. DNA damage, chronic inﬂammation, oxidative stress and</span></div>
<div class="txt" style="position:absolute; left:37px; top:731px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">increasing NAD+ consuming enzymes (sirtuins, CD38/CD157, PARP, TNKS and BST) accelerate NAD degradation. The reduced levels of NAD+ cause downregulation of energy</span></div>
<div class="txt" style="position:absolute; left:37px; top:740px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">production in mitochondria, leading to aging and various age-associated diseases. NMN supplementation can reinstate NAD+ levels in the body through biosynthesis</span></div>
<div class="txt" style="position:absolute; left:37px; top:749px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">pathways, reversing the aging process and preventing age-associated diseases.</span></div>
<div class="txt" style="position:absolute; left:291px; top:764px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">270</span></div>
</body>
</html>
